{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T20:11:48Z","timestamp":1778530308545,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["420386\/2018-1"],"award-info":[{"award-number":["420386\/2018-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["438384\/2018-0"],"award-info":[{"award-number":["438384\/2018-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00213-020-05600-1","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:02:45Z","timestamp":1593734565000},"page":"3149-3159","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Antidepressant-like effect of a selenopropargylic benzamide in mice: involvement of the serotonergic system"],"prefix":"10.1007","volume":"237","author":[{"given":"Evelyn Mianes","family":"Besckow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nat\u00e1lia Tavares","family":"Nonemacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cleisson Schossler","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Nat\u00e3","family":"da Silva Esp\u00edndola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9verton Berwanger","family":"Balbom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiane","family":"Gritzenco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucielli","family":"Savegnago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benhur","family":"Godoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9509-4446","authenticated-orcid":false,"given":"Cristiani Folharini","family":"Bortolatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0814-0203","authenticated-orcid":false,"given":"C\u00e9sar Augusto","family":"Br\u00fcning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,3]]},"reference":[{"key":"5600_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.pharmthera.2012.09.006","volume":"137","author":"F Artigas","year":"2013","unstructured":"Artigas F (2013) Serotonin receptors involved in antidepressant effects. Pharmacol Ther 137:119\u2013131. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.09.006","journal-title":"Pharmacol Ther"},{"key":"5600_CR2","doi-asserted-by":"publisher","unstructured":"Asif M (2016) Pharmacological potential of benzamide analogues and their uses in medicinal chemistry. Modern Chem Appl 4(4). https:\/\/doi.org\/10.4172\/2329-6798.1000194","DOI":"10.4172\/2329-6798.1000194"},{"key":"5600_CR3","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.1016\/j.tet.2019.06.031","volume":"75","author":"EB Balbom","year":"2019","unstructured":"Balbom EB, Gritzenco F, Speran\u00e7a A, Godoi M, Alves D, Barcellos T, Godoi B (2019) Copper-catalyzed Csp-chalcogen bond formation: versatile approach to N-(3-(organochalcogenyl)prop-2-yn-1-yl)amides. Tetrahedron 75:4017\u20134023. https:\/\/doi.org\/10.1016\/j.tet.2019.06.031","journal-title":"Tetrahedron"},{"key":"5600_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1056\/NEJMra073096","volume":"358","author":"RH Belmaker","year":"2008","unstructured":"Belmaker RH, Agam G (2008) Major depressive disorder. N Engl J Med 358:55\u201368. https:\/\/doi.org\/10.1056\/NEJMra073096","journal-title":"N Engl J Med"},{"key":"5600_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pbb.2014.08.002","volume":"125","author":"CA Bruning","year":"2014","unstructured":"Bruning CA, Gai BM, Soares SM, Martini F, Nogueira CW (2014) Serotonergic systems are implicated in antinociceptive effect of m-trifluoromethyl diphenyl diselenide in the mouse glutamate test. Pharmacol Biochem Behav 125:15\u201320. https:\/\/doi.org\/10.1016\/j.pbb.2014.08.002","journal-title":"Pharmacol Biochem Behav"},{"key":"5600_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pnpbp.2015.05.011","volume":"63","author":"CA Bruning","year":"2015","unstructured":"Bruning CA, Martini F, Soares SM, Sampaio TB, Gai BM, Duarte MM, Nogueira CW (2015a) m-Trifluoromethyl-diphenyl diselenide, a multi-target selenium compound, prevented mechanical allodynia and depressive-like behavior in a mouse comorbid pain and depression model. Prog Neuro-Psychopharmacol Biol Psychiatry 63:35\u201346. https:\/\/doi.org\/10.1016\/j.pnpbp.2015.05.011","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5600_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jpsychires.2015.04.019","volume":"66-67","author":"CA Bruning","year":"2015","unstructured":"Bruning CA, Martini F, Soares SM, Savegnago L, Sampaio TB, Nogueira CW (2015b) Depressive-like behavior induced by tumor necrosis factor-alpha is attenuated by m-trifluoromethyl-diphenyl diselenide in mice. J Psychiatr Res 66-67:75\u201383. https:\/\/doi.org\/10.1016\/j.jpsychires.2015.04.019","journal-title":"J Psychiatr Res"},{"key":"5600_CR8","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/FBP.0b013e32833e7e6d","volume":"21","author":"CA Bruning","year":"2010","unstructured":"Bruning CA, Prigol M, Roehrs JA, Zeni G, Nogueira CW (2010) Evidence for the involvement of mu-opioid and delta-opioid receptors in the antinociceptive effect caused by oral administration of m-trifluoromethyl-diphenyl diselenide in mice. Behav Pharmacol 21:621\u2013626. https:\/\/doi.org\/10.1097\/FBP.0b013e32833e7e6d","journal-title":"Behav Pharmacol"},{"key":"5600_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ejphar.2011.02.039","volume":"658","author":"CA Bruning","year":"2011","unstructured":"Bruning CA, Souza AC, Gai BM, Zeni G, Nogueira CW (2011) Antidepressant-like effect of m-trifluoromethyl-diphenyl diselenide in the mouse forced swimming test involves opioid and serotonergic systems. Eur J Pharmacol 658:145\u2013149. https:\/\/doi.org\/10.1016\/j.ejphar.2011.02.039","journal-title":"Eur J Pharmacol"},{"key":"5600_CR10","doi-asserted-by":"crossref","unstructured":"Caliendo G, Santagada V, Perissutti E, Severino B, Fiorino F, Warner TD, Wallace JL, Ifa DR, Antunes E, Cirino G, de Nucci G (2001) Synthesis of substituted benzamides as anti-inflammatory agents that inhibit preferentially cyclooxygenase 1 but do not cause gastric damage. Eur J Med Chem 36: 517-30. doi:","DOI":"10.1016\/S0223-5234(01)01251-X"},{"key":"5600_CR11","doi-asserted-by":"publisher","unstructured":"Castagne V, Moser P, Roux S, Porsolt RD (2011) Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice. Curr Protoc Neurosci Chapter 8: Unit 8 10A. doi: https:\/\/doi.org\/10.1002\/0471142301.ns0810as55","DOI":"10.1002\/0471142301.ns0810as55"},{"key":"5600_CR12","unstructured":"Celada P, Puig M, Amargos-Bosch M, Adell A, Artigas F (2004) The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci 29: 252-65. doi:"},{"key":"5600_CR13","doi-asserted-by":"publisher","first-page":"8165","DOI":"10.1523\/JNEUROSCI.1816-05.2005","volume":"25","author":"L Cervo","year":"2005","unstructured":"Cervo L, Canetta A, Calcagno E, Burbassi S, Sacchetti G, Caccia S, Fracasso C, Albani D, Forloni G, Invernizzi RW (2005) Genotype-dependent activity of tryptophan hydroxylase-2 determines the response to citalopram in a mouse model of depression. J Neurosci 25:8165\u20138172. https:\/\/doi.org\/10.1523\/JNEUROSCI.1816-05.2005","journal-title":"J Neurosci"},{"key":"5600_CR14","first-page":"218","volume":"58","author":"C Chirita","year":"2010","unstructured":"Chirita C, Cristea AN, Negres S, Zbarcea CE, Marineci CE (2010) Antidepressant effect after acute and subacute administration of novel n-substituted benzamides on reserpine-induced depression in mice. Farmacia 58:218\u2013227","journal-title":"Farmacia"},{"key":"5600_CR15","doi-asserted-by":"publisher","first-page":"5493","DOI":"10.1016\/j.bmcl.2004.09.004","volume":"14","author":"SJ Coats","year":"2004","unstructured":"Coats SJ, Schulz MJ, Carson JR, Codd EE, Hlasta DJ, Pitis PM, Stone DJ Jr, Zhang SP, Colburn RW, Dax SL (2004) Parallel methods for the preparation and SAR exploration of N-ethyl-4-[(8-alkyl-8-aza-bicyclo[3.2.1]oct-3-ylidene)-aryl-methyl]-benzamides, powerful mu and delta opioid agonists. Bioorg Med Chem Lett 14:5493\u20135498. https:\/\/doi.org\/10.1016\/j.bmcl.2004.09.004","journal-title":"Bioorg Med Chem Lett"},{"key":"5600_CR16","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1192\/bjp.113.504.1237","volume":"113","author":"A Coppen","year":"1967","unstructured":"Coppen A (1967) The biochemistry of affective disorders. The Br J Psychiatry 113:1237\u20131264. https:\/\/doi.org\/10.1192\/bjp.113.504.1237","journal-title":"The Br J Psychiatry"},{"key":"5600_CR17","doi-asserted-by":"crossref","unstructured":"Cryan JF & Lucki I (2000) Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors. J Pharmacol Exp Ther 295:1120\u20131126","DOI":"10.1016\/S0014-2999(00)00858-X"},{"key":"5600_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tins.2013.10.003","volume":"37","author":"R Dantzer","year":"2014","unstructured":"Dantzer R, Heijnen CJ, Kavelaars A, Laye S, Capuron L (2014) The neuroimmune basis of fatigue. Trends Neurosci 37:39\u201346. https:\/\/doi.org\/10.1016\/j.tins.2013.10.003","journal-title":"Trends Neurosci"},{"key":"5600_CR19","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1007\/s00213-017-4738-y","volume":"234","author":"TJ Donahue","year":"2017","unstructured":"Donahue TJ, Hillhouse TM, Webster KA, Young R, De Oliveira EO, Porter JH (2017) Discriminative stimulus properties of the atypical antipsychotic amisulpride: comparison to its isomers and to other benzamide derivatives, antipsychotic, antidepressant, and antianxiety drugs in C57BL\/6 mice. Psychopharmacology 234:3507\u20133520. https:\/\/doi.org\/10.1007\/s00213-017-4738-y","journal-title":"Psychopharmacology"},{"key":"5600_CR20","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.bmc.2006.12.014","volume":"15","author":"FS Duarte","year":"2007","unstructured":"Duarte FS, Codeco Martins PR, Romeiro GA, Monteiro De Lima TC (2007) Antidepressant-like profile of action of two 4-amine derivatives of 10,11-dihydro-5H-dibenzo [a,d] cycloheptane in mice evaluated in the forced swimming test. Bioorg Med Chem 15:1645\u20131650. https:\/\/doi.org\/10.1016\/j.bmc.2006.12.014","journal-title":"Bioorg Med Chem"},{"key":"5600_CR21","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","volume":"59","author":"RS Duman","year":"2006","unstructured":"Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116\u20131127. https:\/\/doi.org\/10.1016\/j.biopsych.2006.02.013","journal-title":"Biol Psychiatry"},{"key":"5600_CR22","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1017\/S1461145711000083","volume":"14","author":"JM Dupuy","year":"2011","unstructured":"Dupuy JM, Ostacher MJ, Huffman J, Perlis RH, Nierenberg AA (2011) A critical review of pharmacotherapy for major depressive disorder. Int J Neuropsychopharmacol 14:1417\u20131431. https:\/\/doi.org\/10.1017\/S1461145711000083","journal-title":"Int J Neuropsychopharmacol"},{"key":"5600_CR23","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/S0968-0896(99)00185-6","volume":"7","author":"JE Foster","year":"1999","unstructured":"Foster JE, Nicholson JM, Butcher R, Stables JP, Edafiogho IO, Goodwin AM, Henson MC, Smith CA, Scott KR (1999) Synthesis, characterization and anticonvulsant activity of enaminones. Part 6: synthesis of substituted vinylic benzamides as potential anticonvulsants. Bioorg Med Chem 7:2415\u20132425","journal-title":"Bioorg Med Chem"},{"key":"5600_CR24","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","volume":"75","author":"DS Hasin","year":"2018","unstructured":"Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M, Grant BF (2018) Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry 75:336\u2013346. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.4602","journal-title":"JAMA Psychiatry"},{"key":"5600_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.npep.2009.06.004","volume":"43","author":"KM Hegadoren","year":"2009","unstructured":"Hegadoren KM, O'Donnell T, Lanius R, Coupland NJ, Lacaze-Masmonteil N (2009) The role of beta-endorphin in the pathophysiology of major depression. Neuropeptides 43:341\u2013353. https:\/\/doi.org\/10.1016\/j.npep.2009.06.004","journal-title":"Neuropeptides"},{"key":"5600_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/a0038550","volume":"23","author":"TM Hillhouse","year":"2015","unstructured":"Hillhouse TM, Porter JH (2015) A brief history of the development of antidepressant drugs: from monoamines to glutamate. Exp Clin Psychopharmacol 23:1\u201321. https:\/\/doi.org\/10.1037\/a0038550","journal-title":"Exp Clin Psychopharmacol"},{"key":"5600_CR27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1017\/S1461145707008140","volume":"11","author":"J Hirvonen","year":"2008","unstructured":"Hirvonen J, Karlsson H, Kajander J, Lepola A, Markkula J, Rasi-Hakala H, Nagren K, Salminen JK, Hietala J (2008) Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. Int J Neuropsychopharmacol 11:465\u2013476. https:\/\/doi.org\/10.1017\/S1461145707008140","journal-title":"Int J Neuropsychopharmacol"},{"key":"5600_CR28","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.pnpbp.2009.11.023","volume":"34","author":"CR Jesse","year":"2010","unstructured":"Jesse CR, Wilhelm EA, Bortolatto CF, Nogueira CW (2010) Evidence for the involvement of the serotonergic 5-HT2A\/C and 5-HT3 receptors in the antidepressant-like effect caused by oral administration of bis selenide in mice. Prog Neuro-Psychopharmacol Biol Psychiatry 34:294\u2013302. https:\/\/doi.org\/10.1016\/j.pnpbp.2009.11.023","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5600_CR29","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00210-019-01620-7","volume":"392","author":"E Kedzierska","year":"2019","unstructured":"Kedzierska E, Fiorino F, Magli E, Poleszak E, Wlaz P, Orzelska-Gorka J, Knap B, Kotlinska JH (2019) New arylpiperazine derivatives with antidepressant-like activity containing isonicotinic and picolinic nuclei: evidence for serotonergic system involvement. Naunyn Schmiedeberg's Arch Pharmacol 392:743\u2013754. https:\/\/doi.org\/10.1007\/s00210-019-01620-7","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"5600_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fpsyt.2020.00035","volume":"11","author":"Y Luo","year":"2020","unstructured":"Luo Y, Kataoka Y, Ostinelli EG, Cipriani A, Furukawa TA (2020) National prescription patterns of antidepressants in the treatment of adults with major depression in the US between 1996 and 2015: a population representative survey based analysis. Front Psychiatry 11:35. https:\/\/doi.org\/10.3389\/fpsyt.2020.00035","journal-title":"Front Psychiatry"},{"key":"5600_CR31","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.pnpbp.2006.11.004","volume":"31","author":"DG Machado","year":"2007","unstructured":"Machado DG, Kaster MP, Binfare RW, Dias M, Santos AR, Pizzolatti MG, Brighente IM, Rodrigues AL (2007) Antidepressant-like effect of the extract from leaves of Schinus molle L. in mice: evidence for the involvement of the monoaminergic system. Prog Neuro-Psychopharmacol Biol Psychiatry 31:421\u2013428. https:\/\/doi.org\/10.1016\/j.pnpbp.2006.11.004","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5600_CR32","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.2147\/NDT.S150589","volume":"13","author":"RS McIntyre","year":"2017","unstructured":"McIntyre RS (2017) The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone. Neuropsychiatr Dis Treat 13:2913\u20132919. https:\/\/doi.org\/10.2147\/NDT.S150589","journal-title":"Neuropsychiatr Dis Treat"},{"key":"5600_CR33","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1523\/JNEUROSCI.4734-03.2004","volume":"24","author":"Z Merali","year":"2004","unstructured":"Merali Z, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, Anisman H (2004) Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J Neurosci 24:1478\u20131485. https:\/\/doi.org\/10.1523\/JNEUROSCI.4734-03.2004","journal-title":"J Neurosci"},{"key":"5600_CR34","doi-asserted-by":"publisher","first-page":"6255","DOI":"10.1021\/cr0406559","volume":"104","author":"CW Nogueira","year":"2004","unstructured":"Nogueira CW, Zeni G, Rocha JB (2004) Organoselenium and organotellurium compounds: toxicology and pharmacology. Chem Rev 104:6255\u20136285. https:\/\/doi.org\/10.1021\/cr0406559","journal-title":"Chem Rev"},{"key":"5600_CR35","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00213-007-0728-9","volume":"192","author":"OF O'Leary","year":"2007","unstructured":"O'Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME, Lucki I (2007) Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology 192:357\u2013371. https:\/\/doi.org\/10.1007\/s00213-007-0728-9","journal-title":"Psychopharmacology"},{"key":"5600_CR36","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.pnpbp.2005.03.017","volume":"29","author":"M Paez-Pereda","year":"2005","unstructured":"Paez-Pereda M (2005) New drug targets in the signaling pathways activated by antidepressants. Prog Neuro-Psychopharmacol Biol Psychiatry 29:1010\u20131016. https:\/\/doi.org\/10.1016\/j.pnpbp.2005.03.017","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5600_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.pnpbp.2015.10.008","volume":"65","author":"LM Pinto Brod","year":"2016","unstructured":"Pinto Brod LM, Fronza MG, Vargas JP, Ludtke DS, Luchese C, Wilhelm EA, Savegnago L (2016) Involvement of monoaminergic system in the antidepressant-like effect of (octylseleno)-xylofuranoside in the mouse tail suspension test. Prog Neuro-Psychopharmacol Biol Psychiatry 65:201\u2013207. https:\/\/doi.org\/10.1016\/j.pnpbp.2015.10.008","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5600_CR38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1515\/revneuro-2012-0082","volume":"24","author":"NK Popova","year":"2013","unstructured":"Popova NK, Naumenko VS (2013) 5-HT1A receptor as a key player in the brain 5-HT system. Rev Neurosci 24:191\u2013204. https:\/\/doi.org\/10.1515\/revneuro-2012-0082","journal-title":"Rev Neurosci"},{"key":"5600_CR39","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327\u2013336","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"5600_CR40","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1021\/acschembio.6b00031","volume":"11","author":"HJ Reich","year":"2016","unstructured":"Reich HJ, Hondal RJ (2016) Why nature chose selenium. ACS Chem Biol 11:821\u2013841. https:\/\/doi.org\/10.1021\/acschembio.6b00031","journal-title":"ACS Chem Biol"},{"key":"5600_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1039\/c3mt00185g","volume":"6","author":"M Roman","year":"2014","unstructured":"Roman M, Jitaru P, Barbante C (2014) Selenium biochemistry and its role for human health. Metallomics 6:25\u201354. https:\/\/doi.org\/10.1039\/c3mt00185g","journal-title":"Metallomics"},{"key":"5600_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/1073858414561303","volume":"22","author":"BA Samuels","year":"2016","unstructured":"Samuels BA, Mendez-David I, Faye C, David SA, Pierz KA, Gardier AM, Hen R, David DJ (2016) Serotonin 1A and serotonin 4 receptors: essential mediators of the neurogenic and behavioral actions of antidepressants. Neuroscientist 22:26\u201345. https:\/\/doi.org\/10.1177\/1073858414561303","journal-title":"Neuroscientist"},{"key":"5600_CR43","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrd2462","volume":"7","author":"G Sanacora","year":"2008","unstructured":"Sanacora G, Zarate CA, Krystal JH, Manji HK (2008) Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov 7:426\u2013437. https:\/\/doi.org\/10.1038\/nrd2462","journal-title":"Nat Rev Drug Discov"},{"key":"5600_CR44","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.pbb.2007.09.015","volume":"88","author":"L Savegnago","year":"2008","unstructured":"Savegnago L, Jesse CR, Pinto LG, Rocha JB, Barancelli DA, Nogueira CW, Zeni G (2008) Diphenyl diselenide exerts antidepressant-like and anxiolytic-like effects in mice: involvement of L-arginine-nitric oxide-soluble guanylate cyclase pathway in its antidepressant-like action. Pharmacol Biochem Behav 88:418\u2013426. https:\/\/doi.org\/10.1016\/j.pbb.2007.09.015","journal-title":"Pharmacol Biochem Behav"},{"key":"5600_CR45","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.pnpbp.2007.05.006","volume":"31","author":"L Savegnago","year":"2007","unstructured":"Savegnago L, Jesse CR, Pinto LG, Rocha JB, Nogueira CW, Zeni G (2007a) Monoaminergic agents modulate antidepressant-like effect caused by diphenyl diselenide in rats. Prog Neuro-Psychopharmacol Biol Psychiatry 31:1261\u20131269. https:\/\/doi.org\/10.1016\/j.pnpbp.2007.05.006","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5600_CR46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejphar.2006.10.003","volume":"555","author":"L Savegnago","year":"2007","unstructured":"Savegnago L, Pinto LG, Jesse CR, Alves D, Rocha JB, Nogueira CW, Zeni G (2007b) Antinociceptive properties of diphenyl diselenide: evidences for the mechanism of action. Eur J Pharmacol 555:129\u2013138. https:\/\/doi.org\/10.1016\/j.ejphar.2006.10.003","journal-title":"Eur J Pharmacol"},{"key":"5600_CR47","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00210-019-01636-z","volume":"392","author":"S Shakiba","year":"2019","unstructured":"Shakiba S, Rezaee M, Afshari K, Kazemi K, Sharifi KA, Haddadi NS, Haj-Mirzaian A, Kamalian A, Jazaeri SZ, Richter K, Dehpour AR (2019) Evaluation of the pharmacological involvement of ATP-sensitive potassium (KATP) channels in the antidepressant-like effects of topiramate on mice. Naunyn Schmiedeberg's Arch Pharmacol 392:833\u2013842. https:\/\/doi.org\/10.1007\/s00210-019-01636-z","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"5600_CR48","volume-title":"SSRIs and newer antidepressants APA textbook of mood disorders","author":"RC Shelton","year":"2006","unstructured":"Shelton RC, Lester N (2006) SSRIs and newer antidepressants APA textbook of mood disorders. APA Press, Washington, D.C."},{"key":"5600_CR49","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.2174\/1568026619666190911122040","volume":"19","author":"J Sniecikowska","year":"2019","unstructured":"Sniecikowska J, Newman-Tancredi A, Kolaczkowski M (2019) From receptor selectivity to functional selectivity: the rise of biased agonism in 5-HT1A receptor drug discovery. Curr Top Med Chem 19:2393\u20132420. https:\/\/doi.org\/10.2174\/1568026619666190911122040","journal-title":"Curr Top Med Chem"},{"key":"5600_CR50","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1016\/j.bmc.2005.02.016","volume":"13","author":"S Sonda","year":"2005","unstructured":"Sonda S, Kawahara T, Katayama K, Sato N, Asano K (2005) Synthesis and pharmacological evaluation of benzamide derivatives as selective 5-HT(4) receptor agonists. Bioorg Med Chem 13:3295\u20133308. https:\/\/doi.org\/10.1016\/j.bmc.2005.02.016","journal-title":"Bioorg Med Chem"},{"key":"5600_CR51","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/bf00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367\u2013370. https:\/\/doi.org\/10.1007\/bf00428203","journal-title":"Psychopharmacology"},{"key":"5600_CR52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.advms.2017.07.005","volume":"63","author":"S Umukoro","year":"2018","unstructured":"Umukoro S, Adebesin A, Agu G, Omorogbe O, Asehinde SB (2018) Antidepressant-like activity of methyl jasmonate involves modulation of monoaminergic pathways in mice. Adv Med Sci 63:36\u201342. https:\/\/doi.org\/10.1016\/j.advms.2017.07.005","journal-title":"Adv Med Sci"},{"key":"5600_CR53","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.physbeh.2016.12.024","volume":"170","author":"D Velasquez","year":"2017","unstructured":"Velasquez D, Quines C, Pistoia R, Zeni G, Nogueira CW (2017) Selective inhibition of MAO-A activity results in an antidepressant-like action of 2-benzoyl 4-iodoselenophene in mice. Physiol Behav 170:100\u2013105. https:\/\/doi.org\/10.1016\/j.physbeh.2016.12.024","journal-title":"Physiol Behav"},{"key":"5600_CR54","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41397-019-0080-6","volume":"19","author":"A Viglione","year":"2019","unstructured":"Viglione A, Chiarotti F, Poggini S, Giuliani A, Branchi I (2019) Predicting antidepressant treatment outcome based on socioeconomic status and citalopram dose. Pharm J 19:538\u2013546. https:\/\/doi.org\/10.1038\/s41397-019-0080-6","journal-title":"Pharm J"},{"key":"5600_CR55","doi-asserted-by":"crossref","unstructured":"Walsh RN, Cummins RA (1976) The open-field test: a critical review. Psychological bulletin 83: 482-504. doi:","DOI":"10.1037\/0033-2909.83.3.482"},{"key":"5600_CR56","volume-title":"Depression and other common mental disorders: global health estimates","author":"WHO","year":"2017","unstructured":"WHO (2017) Depression and other common mental disorders: global health estimates. World Health Organization. doi, Geneva"},{"key":"5600_CR57","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/iub.1466","volume":"68","author":"JK Wrobel","year":"2016","unstructured":"Wrobel JK, Power R, Toborek M (2016) Biological activity of selenium: revisited. IUBMB Life 68:97\u2013105. https:\/\/doi.org\/10.1002\/iub.1466","journal-title":"IUBMB Life"},{"key":"5600_CR58","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13041-017-0306-y","volume":"10","author":"CN Yohn","year":"2017","unstructured":"Yohn CN, Gergues MM, Samuels BA (2017) The role of 5-HT receptors in depression. Mol Brain 10:28. https:\/\/doi.org\/10.1186\/s13041-017-0306-y","journal-title":"Mol Brain"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05600-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-020-05600-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05600-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T23:37:01Z","timestamp":1625269021000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-020-05600-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,3]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["5600"],"URL":"https:\/\/doi.org\/10.1007\/s00213-020-05600-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,3]]},"assertion":[{"value":"15 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experiments were conducted according to the standards of the UFPel Animal Ethics and Welfare Committee (CEEA 4903-2017), affiliated to the Council for Control of Animal Experiments (CONCEA), and according to the National Institutes of Health Guide for the care and use of laboratory animals (NIH Publications No. 8023, revised 1978). Every effort has been made to minimize animal suffering and reduce the number of animals used in the experiments.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}